Abstract
In the development of a novel vaccine against atopic allergies, we have screened for adjuvants that enhance the therapeutic antibody response against self immunoglobulin E (IgE). The response against self IgE is induced by administration of a vaccine antigen, which contains both self and non-self IgE regions, together with an adjuvant. We evaluated five commonly used adjuvants; Freund's, aluminium hydroxide, ISCOMs, Montanide ISA 51 and Montanide ISA 720, and found that the mineral oil-based adjuvants; Montanide ISA 51 and Freund's induced at least 5-10-fold higher anti-self IgE titers than any of the other candidates. However, with one exception, Alum, the immune responses against the carrier, i.e. the non-self regions, were similar for all adjuvants, indicating that the ability to induce responses against self and non-self antigens differ among adjuvants. The responses against non-self IgE were more than 50-fold higher than antibody responses against self IgE in both the Freund's and Montanide 51-administered animals, indicating that the response against self molecules is markedly inhibited by tolerance-inducing mechanisms. Co-administration of Montanide ISA 51 with immuno-stimulatory substances from bacteria; muramyldipeptid...Continue Reading
References
Jan 1, 1979·Microbiology and Immunology·M TsujimotoT Shiba
Oct 11, 1982·Nucleic Acids Research·L HellmanH Bennich
Jul 1, 1994·Vaccine·J A MumfordR F Cook
Feb 1, 1994·European Journal of Immunology·L Hellman
Feb 1, 1997·American Journal of Reproductive Immunology : AJRI·G P TalwarA Gupta
Apr 1, 1997·Immunology and Cell Biology·G P Talwar
Feb 1, 1997·Vaccine·J C Cox, A R Coulter
Oct 1, 1998·European Journal of Immunology·M Aveskogh, L Hellman
Oct 20, 1999·Methods : a Companion to Methods in Enzymology·J R Baldridge, R T Crane
Nov 5, 1999·Nature Biotechnology·M Singh, D O'Hagan
Jun 6, 2000·Advanced Drug Delivery Reviews·J C CoxI G Barr
Jul 27, 2001·Journal of Immunological Methods·C AnderssonS Ståhl
Apr 23, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Molly VernerssonLars Hellman
Aug 12, 2003·Expert Review of Vaccines·Jerome AucouturierV Ganne
Apr 2, 2008·Expert Review of Vaccines·Reto Crameri
Citations
Oct 29, 2010·Sarcoma·Alfredo PintoDavid Parham
Jul 20, 2010·Immunotherapy·Alexander Link, Martin F Bachmann
May 16, 2007·Infection and Immunity·Anna U BielinskaJames R Baker
Dec 20, 2005·Viral Immunology·M GhorbaniF Diaz-Mitoma
Oct 6, 2015·Immunological Investigations·Robert G E KrauseJ P Dean Goldring
Mar 8, 2008·Expert Review of Vaccines·Lars Hellman
Aug 16, 2008·Journal of Pharmaceutical Sciences·Jennifer H Wilson-WelderBalaji Narasimhan
Oct 20, 2009·Vaccine·Maria RingvallLars Hellman
Jul 30, 2008·International Journal of Pharmaceutics·Surya K Mallapragada, Balaji Narasimhan
Nov 13, 2007·Veterinary Immunology and Immunopathology·Lidija HabjanecJelka Tomasić
Jan 24, 2007·Vaccine·Beata HalassyJelka Tomasić
Dec 6, 2006·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Lars Hellman
Apr 23, 2014·Immunology·Feng-Ying HuangGuang-Hong Tan
Dec 8, 2006·Vaccine·Jeannette Johansson, Lars Hellman
Sep 20, 2005·Vaccine·Anna LedinLars Hellman
Apr 5, 2008·International Immunopharmacology·Lidija HabjanecJelka Tomasić
Oct 29, 2014·Angiogenesis·Xiaodong ZhuangRoy Bicknell
Jul 28, 2015·PloS One·Ying LeiGunnar Nilsson
Dec 21, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Falk SaupeAnna-Karin Olsson
Jan 10, 2018·Frontiers in Immunology·Lars Torkel HellmanZhirong Fu
May 4, 2021·Frontiers in Immunology·Daniel M MrochenBarbara M Bröker